Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Nat Rev Clin Oncol
    October 2017
  1. SIDAWAY P
    Breast Cancer: Abemaciclib effective in combination with aromatase inhibition.
    Nat Rev Clin Oncol. 2017 Oct 17. doi: 10.1038/nrclinonc.2017.
    >> Share

  2. SIDAWAY P
    Breast cancer: LAG3 expression indicates favourable outcomes.
    Nat Rev Clin Oncol. 2017 Oct 10. doi: 10.1038/nrclinonc.2017.
    >> Share

    September 2017
  3. KILLOCK D
    Breast cancer: Short-term NAT reveals resistance.
    Nat Rev Clin Oncol. 2017 Sep 5. doi: 10.1038/nrclinonc.2017.
    >> Share

    August 2017
  4. SIDAWAY P
    Breast Cancer: Evolution of metastatic disease revealed.
    Nat Rev Clin Oncol. 2017 Aug 31. doi: 10.1038/nrclinonc.2017.
    >> Share

  5. SIDAWAY P
    Breast cancer: AKT inhibition effective against TNBC.
    Nat Rev Clin Oncol. 2017 Aug 31. doi: 10.1038/nrclinonc.2017.
    >> Share

  6. SIDAWAY P
    Breast cancer: Brain metastasis detectable in CTCs.
    Nat Rev Clin Oncol. 2017 Aug 22. doi: 10.1038/nrclinonc.2017.
    >> Share

  7. SIDAWAY P
    Breast cancer: 10-year follow-up of the TEAM cohort reported.
    Nat Rev Clin Oncol. 2017 Aug 16. doi: 10.1038/nrclinonc.2017.
    >> Share

  8. METZGER-FILHO O, Winer EP
    Breast cancer: T-DM1 - an important agent in the history of breast cancer management.
    Nat Rev Clin Oncol. 2017 Aug 8. doi: 10.1038/nrclinonc.2017.
    >> Share

  9. STANTON SE, Davidson NE
    Breast cancer: What lies beyond APHINITY for HER2-positive breast cancer?
    Nat Rev Clin Oncol. 2017 Aug 8. doi: 10.1038/nrclinonc.2017.
    >> Share

  10. GINGRAS I, Gebhart G, de Azambuja E, Piccart-Gebhart M, et al
    HER2-positive breast cancer is lost in translation: time for patient-centered research.
    Nat Rev Clin Oncol. 2017 Aug 1. doi: 10.1038/nrclinonc.2017.
    >> Share

    July 2017
  11. KILLOCK D
    Breast cancer: Profiling of ultra-low-risk disease.
    Nat Rev Clin Oncol. 2017 Jul 18. doi: 10.1038/nrclinonc.2017.
    >> Share

  12. HUTCHINSON L
    Prevention: Low-fat diet linked to decline in breast cancer mortality.
    Nat Rev Clin Oncol. 2017 Jul 18. doi: 10.1038/nrclinonc.2017.
    >> Share

    June 2017
  13. ROMERO D
    Breast cancer: Olaparib improves PFS.
    Nat Rev Clin Oncol. 2017 Jun 20. doi: 10.1038/nrclinonc.2017.
    >> Share

  14. SIDAWAY P
    Breast cancer: Microenvironment mediates differential resistance.
    Nat Rev Clin Oncol. 2017 Jun 13. doi: 10.1038/nrclinonc.2017.
    >> Share

    May 2017
  15. KWA M, Makris A, Esteva FJ
    Clinical utility of gene-expression signatures in early stage breast cancer.
    Nat Rev Clin Oncol. 2017 May 31. doi: 10.1038/nrclinonc.2017.
    >> Share

    March 2017
  16. HUTCHINSON L
    Breast cancer: Utidelone: burden relief in pretreated women.
    Nat Rev Clin Oncol. 2017 Mar 2. doi: 10.1038/nrclinonc.2017.
    >> Share

    December 2016
  17. ROMERO D
    Breast cancer: PALOMA-2 - hope beyond the threshold.
    Nat Rev Clin Oncol. 2016 Dec 6. doi: 10.1038/nrclinonc.2016.
    >> Share

    November 2016
  18. ROMERO D
    Breast cancer: MONALEESA-2 and FALCON - PFS advantage.
    Nat Rev Clin Oncol. 2016 Nov 2. doi: 10.1038/nrclinonc.2016.
    >> Share

  19. SIDAWAY P
    Breast cancer: Eribulin effective against male breast cancer.
    Nat Rev Clin Oncol. 2016 Nov 2. doi: 10.1038/nrclinonc.2016.
    >> Share

    September 2016
  20. ROMERO D
    Breast cancer: CTC heterogeneity is dynamic.
    Nat Rev Clin Oncol. 2016 Sep 13. doi: 10.1038/nrclinonc.2016.
    >> Share

  21. KILLOCK D
    Breast cancer: Genetic signature might spare 100,000 women annually from chemotherapy.
    Nat Rev Clin Oncol. 2016 Sep 13. doi: 10.1038/nrclinonc.2016.
    >> Share

    July 2016
  22. KILLOCK D
    Prevention: RANKLing with breast cancer development.
    Nat Rev Clin Oncol. 2016 Jul 12. doi: 10.1038/nrclinonc.2016.
    >> Share

    June 2016
  23. PUHALLA SL, Davidson NE
    Breast cancer: The 21-gene recurrence score - biology remains at the forefront.
    Nat Rev Clin Oncol. 2016 Jun 14. doi: 10.1038/nrclinonc.2016.
    >> Share

    May 2016
  24. HUTCHINSON L
    Genetics: Defining driver mutations in the genomic landscape of breast cancer.
    Nat Rev Clin Oncol. 2016;13:327.
    >> Share

  25. BIANCHINI G, Balko JM, Mayer IA, Sanders ME, et al
    Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.
    Nat Rev Clin Oncol. 2016 May 17. doi: 10.1038/nrclinonc.2016.
    >> Share

  26. KILLOCK D
    New technology: Integrated approach to genetic profiling of blood cancers.
    Nat Rev Clin Oncol. 2016;13:264.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016